Abstract
Background. Human Bocavirus (HBoV), which is an ssDNA virus of the family Parvoviridae, is responsible for 21.5 % of childhood respiratory tract infections (RTIs) annually. Among the four genotypes currently known, HBoV-1 has been associated with acute RTI. Although there have been studies on HBoV in some countries, there is limited information on this virus in sub-Saharan Africa where there is the highest burden of RTI. This study aimed to characterize the circulating strains of HBoV in Ibadan, Nigeria.
Methods. Nasopharyngeal and oropharyngeal swab samples were collected from 333 children ≤5 years old presenting with RTI attending hospitals in Ibadan, whose parents assented, from 2014 to 2015. Twenty-three HBoV isolates were sequenced after a nested PCR and phylogenetic analysis was carried out using mega 6 software.
Results.
A total of 27 children tested positive for the HBoV-1 genotype by PCR and 23 of the 27 isolates were successfully sequenced. The 23 HBoV-1 isolates from this study have been assigned GenBank accession numbers KY701984–KY702006. Phylogram analysis indicated that the isolates belong to the same clades. Six isolates aligned closely to the reference strains ST1 and ST2, while 17 isolates showed a high level of divergence to the reference isolates.
Conclusion.
This study highlights the contribution of HBoV to RTIs in Nigeria and that HBoV-1 strains are associated with the infection.
Keywords: Human Bocavirus 1, childhood respiratory tract infection, phylogenetic analysis, Ibadan
Data Summary
The HBoV1 isolates in this study have been assigned GenBank accession numbers KY701984–KY702006. Figures 1 and 2 are available on Figshare: https://doi.org/10.6084/m9.figshare.18681488 [1].
Background
Respiratory tract infections (RTIs) are responsible for about 25 % of annual childhood deaths worldwide. Human Bocavirus (HBoV) has been linked with 21.5 % of childhood RTI annually [2]. HBoV1 has been associated with childhood RTI in both developed and developing countries, causing some severe cases of bronchopneumonia and bronchiolitis. Studies have shown that the virus is prevalent in children age <5 years, with the four genotypes often causing different clinical symptoms [3]. Also, since the discovery of the virus from nasopharyngeal aspirates in 2005 by Allander and colleagues, it has been observed that HBoV1 is the fourth most common virus in respiratory samples [4].
HBoV is a relatively newly identified DNA virus that belongs to the family Parvoviridae [5]. The virions are small, icosahedral and non-enveloped, with a negative sense and linear single stranded genome of ∼5.3 kb [6]. The HBoV genome codes for two non-structural proteins (NS1 and NP1) and two structural proteins (VP1 and VP2). The virus has been classified into four genotypes: HBoV-1, -2, -3 and -4, based on the nucleotide divergence of the VP1 capsid region [6]. HBoV-1 infection in children is often identified by wheezing, whereas HBoV2–4 has been found to be involved in childhood diarrhoea cases and acute flaccid paralysis [7].
Although studies have been carried out in some parts of Asia, Australia, Europe and America, there is still a dearth of information on circulating strains of the virus in sub-Saharan Africa, especially in Nigeria. However, due to the frequent detection of HBoV in co-infections with several other respiratory viruses, understanding the pathogenicity of the virus has remained a puzzle [8].
The present study aimed to characterize the circulating strains of HBoV among children ≤5 years old in Ibadan, Nigeria, presenting with symptoms of RTI.
Methods
A total of 333 children ≤5 years old, showing signs of acute RTI, whose parents had given consent, were recruited for this study. Sterile swab sticks were used to collect oropharyngeal (OP) and nasopharyngeal (NP) samples from each child and transported immediately to the laboratory in sterile vials containing 2 ml of viral transport medium (VTM). Although the methods followed in this paper address a specific scientific problem, it is hard to include relevant controls in this study. DNA was extracted from the swab samples using a commercial DNA extraction kit by Jena Bioscience (Germany) according to the manufacturer’s instruction. HBoV was detected from the DNA in a nested PCR procedure as described by Kapoor and colleagues [9] using primers targeting the VP1/2 region of the virus genome (Table 1) and red Load Taq Master kit by Jena Bioscience in a 25 µl reaction. The first round of cycling comprised 95 °C for 2 min, 10 cycles at 95 °C for 35 s, 58 °C for 60 s and 72 °C for 60 s (with a decrease of 0.5 °C in annealing temperature after each cycle), 30 cycles at 95 °C for 30 s, 54 °C for 45 s and 72 °C for 45 s, and a final extension of 72 °C for 10 min. The second round had similar conditions to the first, with a difference in the initial annealing temperatures, 60 °C in the first group of cycles and 58 °C in the second [9].
Table 1.
Primer |
Sequence, 5′–3′ |
Sense |
Reference |
---|---|---|---|
HBoV 1F |
CGCCGTGGCTCCTGCTCT |
+ |
[9] |
HBoV 1R |
TGTTCGCCATCACAA AAGATGTG |
− |
|
HBoV 2F |
GGCTCCTGCTCTAGGAAATAA AGAG |
+ |
|
HBoV 2R |
CCTGCTGTTAGGTCGTTGTTGTATGT |
− |
All samples that were positive for HBoV (showing the expected 575 bp) at the end of the second round of the nested PCR were purified and sequenced. The query DNA sequence generated from the 23 HBoV isolates was extracted in Fasta format and manually edited using mega 6 software [9]. Similar sequences to the HBoV sequences in GenBank were checked using the blast (Basic Local Alignment Search Tool) program in the National Center for Biotechnology Information (NCBI) database. WHO HBoV reference sequences were downloaded from NCBI and a multiple alignment with the sequences generated was carried out using mega 6 software. Phylogenetic analysis was performed by neighbour-joining using the cluster w package in mega 6 and maximum-likelihood trees were generated after correcting for multiple substitutions, complete removal of positions that contained gaps and estimating reliability based on 1000 bootstraps. Multiple alignment and phylogenetic analysis of the sample sequences with previous sequences from Nigeria and worldwide was also done.
The nucleic acid sequences generated from the samples was translated into amino acid sequences from the ORFs within each sequence using mega 6 software. The alignment of amino acid sequences of the 23 HBoV isolates was compared with those of the WHO reference strains, Nigerian and other similar strains from around the world. Maximum-likelihood trees were generated after correcting for multiple substitutions, complete removal of positions that contained gaps and estimated reliability based on 1000 bootstraps.
Data entry, cleaning and data analysis were performed using SPSS statistical software, and descriptive statistics were presented using tables, graphs and charts.
Results
A total of 333 children aged 5 years and below presenting with cough, wheeze, breathlessness, fever, nasal congestion, catarrh, vomiting, tonsillitis, otitis media, rash, diarrhoea, lack of appetite, bronchiolitis and bronchopneumonia were recruited from September 2014 to August 2015 from hospitals and health centres in Ibadan, Oyo State, Nigeria. In total, 170 of the children were male and 155 females. Table 2 shows details of the study population.
Table 2.
Variable |
Category |
Frequency |
Gender |
Total positive HBoV |
Percentage |
sd |
P value |
|
---|---|---|---|---|---|---|---|---|
Male/no. positive |
Female/no. positive |
|||||||
Age |
0–6 months |
133 |
68/0 |
65/2 |
2 |
39.9 |
1.636 |
0.001 |
>6 months − 1 year |
51 |
28/1 |
23/1 |
2 |
15.3 |
|||
>1–2 years |
67 |
37/8 |
30/3 |
11 |
20.1 |
|||
>2–3 years |
27 |
12/0 |
15/3 |
3 |
8.1 |
|||
>3–4 years |
29 |
19/2 |
10/3 |
5 |
8.7 |
|||
>4–5 years |
26 |
14/0 |
12/4 |
4 |
7.8 |
|||
Total |
333 |
178/11 |
155/16 |
27 |
Twenty-seven (8.1 %) of the 333 children tested were positive for HBoV infection, 16 (59.3 %) of whom were female. The age group ˃1–2 years showed the highest prevalence. Twenty-three of the total HBoV-positive isolates were sequenced and characterized (Tables 2–4). All the isolates were of HBoV1 genotype. The maximum-likelihood tree and the pairwise distance showed that 17 (out of 23) isolates were highly divergent from the others, although all the 23 isolates were HBoV1 (Figs 1 and 2).
Table 3.
Symptom |
Frequency |
---|---|
Cough |
27 |
Wheeze |
7 |
Breathlessness |
5 |
Fever |
9 |
Nasal congestion |
16 |
Catarrh |
27 |
Vomiting |
3 |
Itches |
0 |
Tonsillitis |
1 |
Diarrhoea |
1 |
Otitis media |
2 |
Rash |
2 |
Anorexia |
7 |
Restlessness |
0 |
Table 4.
Sample ID |
Gender |
Age |
Symptoms |
---|---|---|---|
OLA17 |
F |
4 years |
Cough, nasal congestion, catarrh |
ADO40 |
F |
3 years |
Cough, wheeze, catarrh |
OLA21 |
F |
3 years |
Cough, nasal congestion, catarrh, anorexia |
ADO38 |
F |
2 years |
Cough, wheeze, catarrh |
ADO27 |
F |
1 year |
Cough, wheeze, breathlessness, nasal congestion, catarrh |
ADO45 |
F |
5 years |
Cough, catarrh |
ADO34 |
F |
4 years |
Cough, wheeze, catarrh |
OLA16 |
M |
1 year |
Cough, fever, nasal congestion, catarrh, anorexia |
OLA18 |
F |
1 year |
Cough, nasal congestion, catarrh, otitis |
ADO28 |
F |
2 years |
Cough, catarrh |
OLA23 |
F |
2 months |
Cough, fever, nasal congestion, catarrh |
ADO37 |
M |
3 years |
Cough, wheeze, catarrh |
ADO43 |
F |
3 years |
Cough, catarrh |
ADO49 |
M |
5 years |
Cough, wheeze, catarrh |
ADO29 |
F |
2 years |
Cough, wheeze, catarrh |
ADO44 |
M |
3 years |
Cough, wheeze, catarrh |
OLA36 |
M |
1 year |
Cough, fever, Nasal congestion, anorexia |
OLA34 |
F |
4 years |
Cough, nasal congestion, catarrh, vomiting |
OLA33 |
F |
1 year |
Cough, nasal congestion, catarrh, tonsillitis, anorexia |
OLA24 |
M |
1 year |
Cough, fever, nasal congestion, catarrh, vomiting |
OLA32 |
M |
9 months |
Cough, breathlessness, fever, nasal congestion, catarrh |
OLA46 |
F |
1 year |
Cough, breathlessness, fever, nasal congestion, catarrh, anorexia |
OLA19 |
M |
1 year |
Cough, breathlessness, fever, nasal congestion, catarrh |
The phylogenetic tree reconstructed with the sequenced isolates and WHO reference strains using mega6 [10] showed that the 23 isolates of this study clustered with HBoV1 WHO reference strains, although 17 of the isolates showed a higher divergence (Figs 1 and 2). The divergence of the sequences of the study isolates and the reference strains sequences revealed an overall mean distance of 0.0 within the isolates and 0.1 when compared with WHO reference strains.
Discussion
In this study, HBoV was detected in 8.1 % of the 333 children recruited. The detection rate observed in this study is higher than the 6.8 % reported by Moreno et al. [11] in Argentina, 7.2 % reported by Tran et al. [12] in Vietnam and much higher than the 1.2 % reported by Niang et al [13] in Senegal, but lower than the 16.8 % reported by [14] among Kenyan children. This difference could be as a result of sampling strategy, severity of illness in the children recruited and different climates. Studies have revealed that HBoV infection among children 0–5 years old seems to be higher in cold and rainy seasons, and it has been shown that the virus is involved in RTIs of children yearround, globally. At the time of this study, to the best of our knowledge, there was a paucity of information on HBoV infections among children in Nigeria. Although not significant, females (59.3%) were found to have a higher prevalence of HBoV in this study (Table 2). This is similar to what was previously reported in India by P. Bharaj, et al. [15] and in Saudi-Arabia by Abdel-Moneim, et al. [16], but different from reports by Symekher et al. [14] among Kenyan children and Salmon-Mulanovich et al. [17] among children in South America, whose findings showed a slightly higher prevalence among male children. Children >1–2 years of age had the highest detection rate and showed symptoms of the highest severity (Table 2). This is similar to the findings of Abdel-Moneim et al. [16], whose study showed similar findings among children. Further studies on this virus are required globally to provide more information on its prevalence among children. Among the symptoms observed in children with HBoV in this study, cough (100%) and catarrh (100%) had the highest frequency, whereas vomiting (11%), tonsillitis (3.7%) and diarrhoea (3.7%) were the least observed symptoms (Table 3). The symptoms observed in children positive for HBoV infection in this study are similar to the reports of Hengst et al. [18], Korner et al. (2011) [19], Halise et al. (2016) [20] and Moesker et al. [21]. This suggests that laboratory screening for HBoV should be included in the hospital management of children ≤5 years old presenting with cough, catarrh and other respiratory tract symptoms in Nigeria, in order to provide information on he appropriate course of treatment. In addition, paediatricians need to be well informed on HBoV infection when advising parents or guardians who are involved in home-based care of children showing symptoms of RTI.
Of the 27 HBoV isolates detected in this study, 23 were successfully sequenced. The phylogram generated from the nucleotide sequence of the 23 HBoV isolates in this study and that of HBoV reference strains showed all the isolates clustering with the reference strain of HBoV-1 (Figs 1 and 2). This is similar to the findings of Johanna et al. (2014) [22], Abdel-Moneim et al. [16] and Principi et al., [23], who reported HBoV-1 as the genotype mostly found associated with respiratory distress in children.
Six of the 23 isolates in this study showed a very high level of similarity (40–55 %) with ST1 and ST2, which are the WHO reference strains for the HBoV-1 genotype [5] while the remaining 17 isolates showed lower similarity to the reference strains. The six isolates that clustered most closely to the reference strains for HBoV-1 (Figs 1 and 2) were from children who exhibited symptoms of high severity (Tables 3 and 4). This is similar to the findings of Sebastien et al. (2017) [24] and Vasiliki et al. (2013) [25], whose study indicated that HBoV-1 isolates aligning with the HBoV-1 reference strains are often obtained from children showing symptoms of severe acute RTIs. This could be because the HBoV-1 reference strains were isolated from children with severe acute respiratory tract illness by Allander et al. [5]. The remaining 17 isolates that showed a higher divergence to the reference strains were from children who exhibited less severe symptoms of respiratory tract illness (Table 4). This corroborates the reports of Kapoor et al. [9] and Abdel-Moneim et al. [16], which showed that HBoV-1 was detected from both severely ill children and those presenting with mild respiratory symptoms.
There was low level of diversity in the nucleotide and amino acid differences within the HBoV-1 isolates of this study (i.e. an overall mean distance of 0.0 within the isolates and 0.01 when aligned to the WHO reference strain sequences). This shows the high level of genetic homogeneity exhibited by the HBoV1 isolates of this study, and supports the findings of Allander et al. [5], Arthur et al. [8], Cheng et al. [6] and Ghietto et al. [26]. When comparing the isolates obtained in this study to other isolates in GenBank it was observed that majority of the isolates were closely related to those from Pakistan. This supports the findings of Kantola et al. [3] and Salmón-Mulanovich et al. (2010) [17], which suggests that there is frequent importation of foreign strains of the HBoV-1 genotype, and indicates that tourism plays an important role in transmission of the virus [3].
Finally, the 8.1 % prevalence of HBoV-1 that was found in this study showed that this virus strain is involved in childhood respiratory tract illnesses in Ibadan and is therefore of public health importance in Nigeria. Although the greatest number of HBoV-1 isolates (11) was obtained in January (Table 5), the short duration of the study prevents proper observation of seasonal patterns of HBoV-1 infection among children. Further investigation is needed to better understand the rate of transmission and symptoms in different seasons.
Table 5.
Month of sample collection |
HBoV positive |
Total |
P value |
|
---|---|---|---|---|
Yes |
No |
|||
January |
11 |
29 |
40 |
0.000 |
February |
2 |
23 |
25 |
|
May |
2 |
7 |
9 |
|
June |
0 |
27 |
27 |
|
July |
0 |
17 |
17 |
|
August |
2 |
80 |
82 |
|
September |
1 |
79 |
80 |
|
October |
0 |
6 |
6 |
|
November |
1 |
6 |
7 |
|
December |
8 |
32 |
40 |
|
Total |
27 |
306 |
333 |
Conclusion
RTIs are implicated in a large number of childhood deaths globally, and HBoV-1 has been shown to be involved in the respiratory illness of children ≤5 years old. The findings of this study show that HBoV-1 is endemic in Ibadan and might be actively circulating among children in Nigeria. Also, there is a likelihood that the movement of people fromone country to another plays an active role in the transmission and evolution of the virus. This study therefore shows the need for continuous surveillance of HBoV and laboratory investigation of the role it plays in the disease process. It is also important to promote good hygienic practices in Nigeria.
Funding information
The authors received no specific grant from any funding agency.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Ethical statement
Ethical approval was obtained from the UI – UCH Ethical Review Committee and permission was obtained from some selected hospital boards before the commencement of this study. Parental informed consents was also obtained for each participant.
Footnotes
Abbreviations: HBoV, Human Bocavirus; NP, nasopharyngeal; OP, oropharyngeal; ORF, open reading frame; PCR, polymerase chain reaction; RTI, respiratory tract infection.
References
- 1.Olajumoke OJ, Johnson AA, Adedayo OF. Human bocavirus infection among children with respiratory tract infection in ibadan, nigeria. Figshare. 2022 doi: 10.1099/acmi.0.000356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Oluwabukola MA, Esa R, Carita SK, Thedi Z, Bamidele AI, et al. Specific viruses detected in nigerian children in association with acute respiratory disease. J Trop Med. 2012;690286:6. doi: 10.1155/2011/690286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kantola K, Hedman L, Arthur J, Alibeto A, Delwart E, et al. Seroepidemiology of human bocaviruses 1-4. J Infect Dis. 2011;204:1403–1412. doi: 10.1093/infdis/jir525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Jartti T, Söderlund-Venermo M, Allander T, Vuorinen T, Hedman K, et al. No efficacy of prednisolone in acute wheezing associated with human bocavirus infection. Pediatr Infect Dis J. 2011;30:521–523. doi: 10.1097/INF.0b013e318216dd81. [DOI] [PubMed] [Google Scholar]
- 5.Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102:12891–12896. doi: 10.1073/pnas.0504666102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cheng W, Chen J, Xu Z, Yu J, Huang C, et al. Phylogenetic and recombination analysis of human bocavirus 2. BMC Infect Dis. 2011;11:50. doi: 10.1186/1471-2334-11-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chow BDW, Ou Z, Esper FP. Newly recognized bocaviruses (HBoV, HBoV2) in children and adults with gastrointestinal illness in the United States. J Clin Virol. 2010;47:143–147. doi: 10.1016/j.jcv.2009.11.030. [DOI] [PubMed] [Google Scholar]
- 8.Arthur JL, Higgins GD, Davidson GP, Givney RC, Ratcliff RM. A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog. 2009;5:e1000391. doi: 10.1371/journal.ppat.1000391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kapoor A, Simmonds P, Slikas E, Li L, Bodhidatta L, et al. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis. 2010;201:1633–1643. doi: 10.1086/652416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–2729. doi: 10.1093/molbev/mst197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Moreno L, Eguizábal L, Ghietto LM. Human bocavirus respiratory infection in infants in Córdoba, argentina. Arch Argent Pediatr. 2014;114:70–74. doi: 10.5546/aap.2014.eng.70. [DOI] [PubMed] [Google Scholar]
- 12.Tran DN, Nguyen TQN, Nguyen TA, Hayakawa S, Mizuguchi M, et al. Human bocavirus in children with acute respiratory infections in Vietnam. J Med Virol. 2014;86:988–994. doi: 10.1002/jmv.23789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Niang MN, Diop OM, Sarr FD, Goudiaby D, Malou-Sompy H, et al. Viral etiology of respiratory infections in children under 5 years old living in tropical rural areas of Senegal: The EVIRA project. J Med Virol. 2010;82:866–872. doi: 10.1002/jmv.21665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Symekher SML, Gachara G, Simwa JM, Gichogo J, Rotich M, et al. Human bocavirus infection in children with acute respiratory infection in Nairobi, Kenya. OJMM. 2013;03:234–238. doi: 10.4236/ojmm.2013.34035. [DOI] [Google Scholar]
- 15.Bharaj P, Sullender WM, Kabra SK, Broor S. Human bocavirus infection in children with acute respiratory tract infection in India. J Med Virol. 2010;82:812–816. doi: 10.1002/jmv.21637. [DOI] [PubMed] [Google Scholar]
- 16.Abdel-Moneim AS, Kamel MM, Al-Ghamdi AS, Al-Malky MIR. Detection of bocavirus in children suffering from acute respiratory tract infections in Saudi Arabia. PLoS One. 2013;8:e55500. doi: 10.1371/journal.pone.0055500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Salmón-Mulanovich G, Sovero M, Laguna-Torres VA, Kochel TJ, Lescano AG, et al. Frequency of human bocavirus (HBoV) infection among children with febrile respiratory symptoms in Argentina, Nicaragua and Peru. Influenza Other Respir Viruses. 2011;5:1–5. doi: 10.1111/j.1750-2659.2010.00160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hengst M, Häusler M, Honnef D, Scheithauer S, Ritter K, et al. Human Bocavirus-infection (HBoV): an important cause of severe viral obstructive bronchitis in children. Klin Padiatr. 2008;220:296–301. doi: 10.1055/s-0028-1083806. [DOI] [PubMed] [Google Scholar]
- 19.Körner RW, Söderlund-Venermo M, van Koningsbruggen-Rietschel S, Kaiser R, Malecki M, et al. Severe human bocavirus infection, Germany. Emerg Infect Dis. 2011;17:2303–2305. doi: 10.3201/eid1712.110574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Akça H, Tuygun N, Polat E, Karacan CD. Severe respiratory tract infections with human bocavirus in children. Journal of Microbiology and Infectious Diseases. 2016;6:145–147. doi: 10.5799/jmid.v6i30451.328994. [DOI] [Google Scholar]
- 21.Moesker FM, van Kampen JJA, van der Eijk AA, van Rossum AMC, de Hoog M, et al. Human bocavirus infection as a cause of severe acute respiratory tract infection in children. Clin Microbiol Infect. 2015;21:964. doi: 10.1016/j.cmi.2015.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nokso-Koivisto J, Pyles RB, Miller AL, Jennings K, Loeffelholz M, et al. Role of human bocavirus in upper respiratory tract infections and acute otitis media. J Pediatric Infect Dis Soc. 2014;3:98–103. doi: 10.1093/jpids/pit061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Principi N, Piralla A, Zampiero A, Bianchini S, Umbrello G, et al. Bocavirus infection in otherwise healthy children with respiratory disease. PLoS ONE. 2015;10:e0135640. doi: 10.1371/journal.pone.0135640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kenmoe S, Vernet M-A, Njankouo-Ripa M, Penlap VB, Vabret A, et al. Phylogenic analysis of human bocavirus detected in children with acute respiratory infection in Yaounde, Cameroon. BMC Res Notes. 2017;10:293. doi: 10.1186/s13104-017-2620-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pogka V, Moutousi A, Kossyvakis A, Kalliaropoulos A, Sgouras DN, et al. Genetic variability of human metapneumo- and bocaviruses in children with respiratory tract infections. Influenza Other Respir Viruses. 2014;8:107–115. doi: 10.1111/irv.12185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Ghietto LM, Cámara A, Cámara J, Adamo MP. High frequency of human bocavirus 1 DNA in infants and adults with lower acute respiratory infection. J Med Microbiol. 2012;61:548–551. doi: 10.1099/jmm.0.035600-0. [DOI] [PubMed] [Google Scholar]